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Abstract
Backgrounds: A two-stage revision arthroplasty was suggested optimal treatment for deep infections in hip joint.
The effect of endoskeleton of cement spacers on the interim function and infection control remains unclear.
Methods: From Jan. 2004 to Dec. 2007, we collected a prospective cohort of consecutive 34 patients who treated
with two-stage revision total hip arthroplasty for deep infection of hip joint. In group 1, fifteen patients were
treated by a novel design augmented with hip compression screw while nineteen patients were treated by
traditional design in group 2.
Results: No fracture of cement spacer occurred in group 1 while 6 cases developed spacer failure in group 2. (p <
0.05) There were significant differences in bodily pain and general health perception between groups (p < 0.05).
Conclusions: Patients being treated for deep infection of hip joint using cement spacer augmented with stronger
endoskeleton have lower pain levels and better joint function between stages.
Background
A two-stage revision arthroplasty was suggested as the
gold standard treatment among many therapeutic alter-
natives for deep infections in the hip joint [1-6] Various
design of antibiotics impregnated cement prosthesis,
either custom made or commercially available [7],
reported advantages such as effective local antibiotics
delivery, continuation of patient mobility, maintenance
of limb alignment, and facilitation of re-implantation,
contributed to the good functional recovery after revi-
sion total hip arthroplasty (THA) [8-12]. However, frac-
ture of the cement spacer occurred which might
decrease ambulation ability and leg length discrepancy
[10,11,13], and demand an additional surgery for
exchange [9] (Figure 1). The introduction of metallic
endoskeleton such as Kirschner wires [11,14], Rush rod
[8,10], hip compression screws, intramedullary nail [15],
and even custom made rod [16] aimed to increase the
strength of the construct. Among those designs of
endoskeleton, hip compression screw was of particular
interest because it was privileged by providing angular sta-
bility that augmented the weakest link of the cement spacer
[17]. It was possible that mechanical instability, pain, and
cement spacer dislocation might be avoided through
increasing the strength of these cement spacers [10,11,13].
It was unclear whether different designs of endoskele-
ton might affect the results of interim function, infection
control, and mechanical complications. The purpose of
this study was to investigate the effect of antibiotic
impregnated cement prosthesis augmented with hip
compression screw as compared to those of Kirschner
wires in treating infected THA. We hypothesized that
the stronger endoskeleton would reduce the incidence
of cement prosthesis fracture and increase the functional
results.
Methods
We collected a cohort of consecutive 34 patients who
were treated with two-stage revision THA for deep
infection of hip joint in Chang-Gung Memorial Hospital
at Chia-Yi from January 2004 to December 2007. This
study was approved by internal board review of Chang
Gung Memorial Hospital (CGMH 98-0330B). Patients
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endoskeleton for cement spacer. In the study period, fif-
teen patients were treated with antibiotic impregnated
cement spacer augmented with hip compression screw
after resection arthroplasty, which were assigned as
group 1, whereas nineteen patients were treated with
antibiotic impregnated cement spacer augmented with
3.0 Kirschner wires, which were assigned as group 2.
The diagnosis of infection was made on clinical exami-
nation, presence of a discharge sinus, frank purulent fluid
or pus found during on explorative operation, or positive
findings on laboratory and histopathologic tests [18].
The first-stage procedure consisted of excision of the
sinuses, removal of all implants, hardware, cement, and
adequate debridement as well as sequestrectomy for
necrotic and infected bone. Three sets of bacterial cul-
ture (both aerobic and anaerobic) were taken from the
joint fluid, soft tissue and infected bone during debride-
ment. A custom-made metal molds for fabricating the
cement prosthesis was developed as previously described
[11]. A regimen of 4 gm of vancomycin and 8 gm of
piperacillin antibiotic power were mixed with each pack-
age of 40 gm of cement polymer (Zimmer Inc., Warsaw,
IN). Processed hip compression screw (in group 1) and
3.0 mm Kirschner wires (in group 2) were fabricated as
endoskeletons. Specifically, the hip compression screw
consisted of 75 mm lag screw and 5-6 holes of side
plate (depend on the patient’s leg length) was assembled
after the side plate was machined to 13 mm in width.
The femoral canal was reamed to 13 mm in diameter
and the acetabulum was reamed to 56 mm in diameter.
The fixation was achieved by manually cementing the
cement prosthesis to the proximal part of the host
femur. The acetabular component was shaped by a uni-
polar cup. The patients were encouraged to walk with
toe-touch weight-bearing. The hip joint movement was
allowed between 0 to 90 degrees as tolerated. The sec-
ond-stage procedure was performed after the wound
healed, along with erythrocyte sedimentation rate and
serum C-reactive protein (CRP) both returned to normal
range. Two sets of bacterial culture were obtained dur-
ing revision arthroplasty.
Evaluation
The fracture of cement spacer was evaluated with ante-
roposterior and lateral radiographs of the hip and gross
assessment for fracture or fragmentation during the
second stage procedure. Subjective outcome before sec-
ond-stage procedure was evaluated with the Medical
Outcomes Study Short-Form 36 (SF-36) Health Survey
[19]. The SF-36 is a multi-purpose, short-form health
survey which yields an 8-scale profile of functional
Figure 1 Fracture of cement spacers may occur in either multiple small diameter Kirschner wires (Figure 1A) or single large diameter
Kirschner wire (Figure 1B).
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based physical and mental health summary measures
and a preference-based health utility index.
Statistic analysis
The proportion of cement spacer fracture was compared
between groups using Fisher’s exact method. Functional
outcome was analyzed by Sign rand sum test. Signifi-
cance was set at 0.05. Re-infection was defined as a
recurrence of inflammation with a positive culture or
clear radiological and serological evidence of sepsis.
Results
In group 1, fifteen patients (9 men and 6 women; age
65.9 years, range 36-87 years; body weight 63.5 kg,
range 50-74 kg) were included (Table 1) while nineteen
patients (13 men and 6 women; age 64.1 years, range
45-80 years; body weight 65.9 kg, range 45-78 kg) were
included in group 2 (Table 2). There were no significant
differences between groups in demographic data.
No fracture of cement spacer occurred in group 1 while
6 cases developed spacer failure in group 2. All fractures
occurred over the neck of cement spacers. The differ-
ences in proportion of cement spacer fracture between
these two groups were statistically significant. (p < 0.05)
In SF-36 evaluation, group 1 revealed better bodily pain
and general health perception as compared to group 2.
(bodily pain, group 1 vs. group 2 = 54 ± 6, vs. 41 ± 7, p <
0.05; general health perception, group 1 vs. group 2 = 51 ±
5 vs. 38 ± 7, p < 0.05) in patient oriented assessment
before second stage procedure. (Figure 2)
Interim period between stages averaged 7.2 months
(ranged from 5.4 to 9.6 months) for group 1 and
6 . 7m o n t h s( r a n g e df r o m4 . 8t o1 1 . 5m o n t h s )f o rg r o u p
2, respectively. Gram-positive microorganism, predomi-
nantly Staphylococcus was the most common organism
found in the tissue culture during first stage procedure.
All cases in our study, both group 1 and group 2, had
good infection control after the first-stage procedure
and there was no evidence of infection while performed
second stage operation. A patient with left primary hip
septic arthritis in group 1 was demonstrated. (Figure 3)
Three patients refuse revision THA because well toler-
ance to the cement prosthesis augmented with hip com-
pression screw (case 10, 11 and 15).
Discussion
The most important finding in the current study was
that stronger endoskeleton, such as hip compression
screw, in the cement spacer could decrease the cement
spacer fracture and hence to improve the interim func-
tional outcome. Fracture of the cement spacer over the
neck usually resulted in dislocation of hip joint. The soft
tissue envelope of hip joint might then be attenuated.
Meanwhile, the superior and posterior acetabular bone
stock might also be destroyed. Both consequences
increased the difficulties in reconstruction of acetabu-
lum during revision hip arthroplasty. In the current
study, no cement facture or dislocation was reported in
the group 1 whereas 6 cases developed cement spacer
neck fracture in the group 2. These results correlated
with the SF-36 evaluation that patients reported better
f u n c t i o n a lr e s u l t si ng r o u p1a sc o m p a r e dt ot h o s ei n
group 2.
For treatment of infected THA, a two-stage technique
which allows identification of the infecting organism,
ascertainment of antibiotic sensitivity and modifying
instruction of antibiotic therapy before reimplantation.
Table 1 Demographic data in Group 1
Patient No. Sex Age Etiology Side Pathology Fracture of DHS augmented cement prosthesis Revision THA
1 M 36 THA infection R Staphy.aureus No Yes
2 F 87 Septic hip L No growth No Yes
3 F 54 Septic hip L No growth No Yes
4 M 55 Septic hip R Staphy.aureus No Yes
5 M 87 Septic hip R No growth No Yes
6 F 84 Septic hip L Staphy.aureus No Yes
7 M 58 Septic hip L Viridans streptococcus No No
8 M 44 Septic hip L Staphy.aureus No Yes
9 M 67 THA infection R No growth No Yes
10 F 83 THA infection R B-Strepto.Gr.B No No
11 M 66 THA infection L Staphy.aureus No No
12 F 72 THA infection R No growth No Yes
13 M 56 THA infection L Strepto. Gr.D No Yes
14 F 68 Septic hip R No growth No Yes
15 M 72 THA infection R Staphy.aureus No No
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method in delivering antibiotics with a high initial
release and progressively decreases over a period of time
to the infection site. Two-stage exchange offers the
greater success rate than one-stage exchange with anti-
biotic-loaded cement in literature [20]. Penner et al.
suggested combined antibiotics in the cement can
increase the amount and duration of antibiotic elution
[21]. On the other hand, literature also suggested that
the release of commercially-impregnated antibiotics
from hip spacer is significantly increase in the presence
of an endoskeleton, whereas the elution of additional
incorporated antibiotic is decreased [16]. In the present
s t u d y ,ar e g i m e no f4g mo fv a n c o m y c i na n d8g mo f
piperacillin was added to each package of 40 gm of
cement polymer with metallic endoskeleton augmenta-
tion. The cultures of tissue obtained at the second stage
were negative in all the patients and there were no
infections which required reoperation after the second
stage. Even though it was demonstrated successful infec-
tion control in this study, further investigation in the in
vivo elution characteristics of metallic endoskeleton aug-
mented cement spacer was suggested.
The mechanical properties of hip spacers containing a
metallic endoskeleton under experimental conditions
were investigated in several studies. Kummer et al.
reported that hip spacer containing Charnley prosthesis
was stronger than that containing Steinmann pins or a
short intramedullary nail and was equivalent in strength
to the commercial spacer [15]. Another study showed
gentamycin-loaded spacers containing double K-wires as
endoskeleton showed an average failure load of 1.6 kN [22].
All failures occurred in the upper third of stem.
Whereas, Thielen et al. showed that presence of endos-
keleton significantly strengthen hip spacers, which toler-
ated hip joint force even up to 6.0 kN, enough for daily
activities under protection [23,24]. Our study, though
lacking the result of experimental mechanical test,
showed a favorable clinical result with stronger endos-
keleton. No case with spacer fracture was demonstrated
in group 1.
Moreover, the mechanical strength of cement is not
only influenced by the type of antibiotic and atmospheric
pressure, but also by the ratio in which the antibiotics are
mixed into the cement [25]. There is no consensus at
quantitative information regarding the ideal antibiotic/
cement ratio, but most surgeons do not exceed a ratio of
10% [26]. On the other hand, previous study showed that
there was a trend of decrease in elution of linezoid in the
presence of endoskeleton [16]. In this study, a higher
local concentration was targeted by regimen of 4 gm of
vancomycin and 8 gm of piperacillin in each package of
40 gm of cement polymer, which may lead to reduced
mechanical properties. In this concern, we utilized hip
compression screw as endoskeleton to enhance strength
of hip spacers. Using this novel design with high dose
antibiotics, the current study achieve satisfactory infec-
tion control and avoid mechanical complications.
Most studies use custom-made, antibiotic-load stan-
dardized cement spacer which works like unipolar
hemiarthroplasty prosthesis [8-10,12,14]. Using those
cement spacers, there is concern of violation of the
acetabular bone which might cause pain and further
erosion during weight-bearing activity. The current
Table 2 The demographic data in group 2
Patient No. Sex Age Etiology Side Bacterial Culture Pathology Fracture of K-pin augmented cement prosthesis Revision THA
1 M 68 THA infection R Peptostreptococcus sp NO YES
2 M 57 Septic hip L Viridans streptococcus(B) NO YES
3 M 80 THA infection L No growth NO YES
4 M 45 THA infection R No growth YES (spacer neck) YES
5 M 56 Bipolar infection R No growth NO YES
6 M 62 THA infection L Staphy.aureus NO YES
7 F 80 THA infection R No growth YES (spacer neck) YES
8 M 45 Septic hip L Staphy. aeureus NO YES
9 F 77 THA infection R Staphy.aureus NO YES
10 M 71 Septic hip L E. Cloacae YES (spacer neck) YES
11 F 59 THA infection R Staphy. aureus NO YES
12 F 77 Septic hip L No growth NO YES
14 F 73 THA infection L Staphy. aureus NO YES
15 M 66 THA infection L Staphy. aureus YES (spacer neck) YES
16 M 46 THA infection R No growth NO YES
17 M 54 THA infection R No growth YES (spacer neck) YES
18 M 75 THA infection R Staphy. aureus YES (spacer neck) YES
19 M 62 THA infection L Ps.aeruginosa NO YES
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struct a hand-mold antibiotic-load cement spacer
with a cement-on-cement articulation. Partial weight-
bearing can be allowed and interim function was
improved between stages.
Three patients in our study refuse the second-stage sur-
gery because satisfaction of antibiotic impregnated cement
prosthesis augmented with hip compression screw.
Although full mobility was not possible, most patients
reported an acceptable level of pain and adequate function
with use of crutches and toe-tough weight-bearing on the
involved extremity. These patients have been deemed
clinically clear of infection. For patients suffered high-risk
multiple medical disease and was considered surgical
candidates, the cement spacer augmented with stronger
endoskeleton might provide an alternative solution.
Limitations of present study should be addressed.
First, number of patients in each group was relatively
small. Second, the study design is prospective without
randomization. Two groups of patients received therapy
in different time period may introduce bias to the
results despite of the same orthopedic surgeron. A lar-
ger scale of patients with long term follow-up and ran-
domization was warranted.
Conclusions
In conclusion, this study shows the continued advan-
tages of using antibiotic impregnated cement prosthesis
Figure 2 In SF-36 evaluation before second-stage procedure, group 1 revealed better bodily pain and general health perception as
compared to group 2. ( bodily pain, group 1 v.s. group 2 = 54 ± 6, v.s. 41 ± 7, p < 0.01; general health perception, group 1 v.s. group 2 = 51 ± 5
v.s. 38 ± 7, p < 0.01) PF: physical functioning, RP: role limitations, BP: bodily pain, GH: general health perceptions, VT: vitality, energy or fatigue,
SF: social functioning, RE: role limitations due to emotional problems, MH: general mental health, PCS: physical component status, MCS: mental
component status.
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augmented with hip compression screw after resection arthroplasty. D: After stabilization of infection, revision total hip arthroplasty
is performed.
Peng et al. BMC Musculoskeletal Disorders 2011, 12:10
http://www.biomedcentral.com/1471-2474/12/10
Page 6 of 7augmented with hip compression screw in two-stage
exchange including cost-effective, successful infection
eradication, facilitation of reimplantation. Stronger
endoskeleton provided strength to reduce fracture of
cement prosthesis. Patients being treated for deep joint
infections using cement spacer augmented with stronger
endoskeleton have lower pain levels and better joint
function.
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